Adenosine a2a and a2b receptor dual antagonists for immuno-oncology
US-2023322785-A1 · Oct 12, 2023 · US
This page is not indexed by search engines while we improve data quality.
Graham Thomas H patents
Graham Thomas H holds 13 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 13 |
| Recent patents | 1 |
| First publication | Nov 3, 2016 |
| Latest publication | Oct 12, 2023 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
7-, 8-, and 10-SUBSTITUTED AMINO TRIAZOLO QUINAZOLINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE
US-2023054411-A1 · Feb 23, 2023 · US
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
US-2022040184-A1 · Feb 10, 2022 · US
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
US-2021395255-A1 · Dec 23, 2021 · US
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
US-11161854-B2 · Nov 2, 2021 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Adenosine a2a and a2b receptor dual antagonists for immuno-oncology
US-2023322785-A1 · Oct 12, 2023 · US
7-, 8-, and 10-SUBSTITUTED AMINO TRIAZOLO QUINAZOLINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE
US-2023054411-A1 · Feb 23, 2023 · US
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
US-2022040184-A1 · Feb 10, 2022 · US
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
US-2021395255-A1 · Dec 23, 2021 · US
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
US-11161854-B2 · Nov 2, 2021 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 13 |
| Human Necessities | 11 |